JPS52139713A - Sustained release cefalexin preparations - Google Patents

Sustained release cefalexin preparations

Info

Publication number
JPS52139713A
JPS52139713A JP5492576A JP5492576A JPS52139713A JP S52139713 A JPS52139713 A JP S52139713A JP 5492576 A JP5492576 A JP 5492576A JP 5492576 A JP5492576 A JP 5492576A JP S52139713 A JPS52139713 A JP S52139713A
Authority
JP
Japan
Prior art keywords
cefalexin
sustained release
preparations
preparation
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5492576A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5547611B2 (nl
Inventor
Hideyuki Maekawa
Yasushi Takagishi
Hiroshi Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Priority to JP5492576A priority Critical patent/JPS52139713A/ja
Priority to CA276,514A priority patent/CA1085296A/en
Priority to NZ183927A priority patent/NZ183927A/xx
Priority to NL7704879A priority patent/NL7704879A/nl
Priority to PT66514A priority patent/PT66514B/pt
Priority to ZA00772757A priority patent/ZA772757B/xx
Priority to IE940/77A priority patent/IE45415B1/en
Priority to AU25078/77A priority patent/AU508793B2/en
Priority to DK208077A priority patent/DK208077A/da
Priority to FI771491A priority patent/FI771491A/fi
Priority to SE7705502A priority patent/SE426780B/xx
Priority to ES458710A priority patent/ES458710A1/es
Priority to GB19853/77A priority patent/GB1543543A/en
Priority to AT341877A priority patent/AT351159B/de
Priority to SU772485596A priority patent/SU1218919A3/ru
Priority to PL1977198058A priority patent/PL111183B1/pl
Priority to FR7714616A priority patent/FR2350836A1/fr
Priority to HU77SI1575A priority patent/HU184196B/hu
Priority to RO7790312A priority patent/RO72935A/ro
Priority to IL52075A priority patent/IL52075A/xx
Priority to GR53444A priority patent/GR68895B/el
Priority to MX775739U priority patent/MX5976E/es
Priority to DE19772721785 priority patent/DE2721785A1/de
Priority to CS773167A priority patent/CS208196B2/cs
Priority to AR267621A priority patent/AR224494A1/es
Priority to DD7700198922A priority patent/DD132232A5/xx
Priority to BE177585A priority patent/BE854640A/xx
Publication of JPS52139713A publication Critical patent/JPS52139713A/ja
Publication of JPS5547611B2 publication Critical patent/JPS5547611B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
JP5492576A 1976-05-13 1976-05-13 Sustained release cefalexin preparations Granted JPS52139713A (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
JP5492576A JPS52139713A (en) 1976-05-13 1976-05-13 Sustained release cefalexin preparations
CA276,514A CA1085296A (en) 1976-05-13 1977-04-20 Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
NZ183927A NZ183927A (en) 1976-05-13 1977-04-26 Long-acting cefalexin preparation
NL7704879A NL7704879A (nl) 1976-05-13 1977-05-03 Langwerkend cefalexinepreparaat.
PT66514A PT66514B (en) 1976-05-13 1977-05-05 Process for long acting preparation of cefalexin for effective treatments of bacterial infections sensitive to cefalexin
ZA00772757A ZA772757B (en) 1976-05-13 1977-05-09 Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
IE940/77A IE45415B1 (en) 1976-05-13 1977-05-09 Long acting preparation of cefalexin
AU25078/77A AU508793B2 (en) 1976-05-13 1977-05-11 Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
DK208077A DK208077A (da) 1976-05-13 1977-05-11 Cefalexinpreparat
FI771491A FI771491A (nl) 1976-05-13 1977-05-11
SE7705502A SE426780B (sv) 1976-05-13 1977-05-11 Forfarande for framstellning av ett cefalexinpreparat
ES458710A ES458710A1 (es) 1976-05-13 1977-05-11 Un metodo para la obtencion de un preparado de cefalexina deaccion prolongada.
GB19853/77A GB1543543A (en) 1976-05-13 1977-05-11 Long acting preparation of cefalexin
AT341877A AT351159B (de) 1976-05-13 1977-05-12 Verfahren zur herstellung eines cephalexin- praeparates mit teilweise verzoegerter wirkstoff- abgabe zur oralen verabreichung beim menschen
SU772485596A SU1218919A3 (ru) 1976-05-13 1977-05-12 Способ получени цефалексина продленного действи дл перорального применени
PL1977198058A PL111183B1 (en) 1976-05-13 1977-05-12 Method of obtaining a cephaloxine preparation
FR7714616A FR2350836A1 (fr) 1976-05-13 1977-05-12 Preparation de cefalexine a longue duree d'action pour le traitement efficace d'infections bacteriennes sensibles a la cefalexine
HU77SI1575A HU184196B (en) 1976-05-13 1977-05-12 Process for producing preparation containing 7-/d-2-amino-2-phenylacetamino/-3-methyl-3-cephem-4-carboxylic acid monohydrate
RO7790312A RO72935A (ro) 1976-05-13 1977-05-12 Procedeu de obtinere a unui preparat cu cefalexina cu actiune prelungita pentru administrare orala in medicina umana
IL52075A IL52075A (en) 1976-05-13 1977-05-12 Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
GR53444A GR68895B (nl) 1976-05-13 1977-05-12
MX775739U MX5976E (es) 1976-05-13 1977-05-12 Procedimiento mejorado para preparar una composicion farmaceutica a partir de cefalexina
DE19772721785 DE2721785A1 (de) 1976-05-13 1977-05-13 Oral verabfolgbares cephalexinpraeparat mit verzoegerter wirkstoffabgabe
CS773167A CS208196B2 (en) 1976-05-13 1977-05-13 Method of making the perorally applicable preparation with the retarded liberation of the cefalexine as the active component
AR267621A AR224494A1 (es) 1976-05-13 1977-05-13 Un procedimiento para preparar cefalexina de accion prolongada
DD7700198922A DD132232A5 (de) 1976-05-13 1977-05-13 Verfahren zur herstellung eines oral verabfolgbaren cephalexinpraeparates mit verzoegerter wirkstoffabgabe
BE177585A BE854640A (fr) 1976-05-13 1977-05-13 Preparation de cefalexine a action prolongee pour le traitement efficace des infections par bacteries sensibles a la cefalexine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5492576A JPS52139713A (en) 1976-05-13 1976-05-13 Sustained release cefalexin preparations

Publications (2)

Publication Number Publication Date
JPS52139713A true JPS52139713A (en) 1977-11-21
JPS5547611B2 JPS5547611B2 (nl) 1980-12-01

Family

ID=12984185

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5492576A Granted JPS52139713A (en) 1976-05-13 1976-05-13 Sustained release cefalexin preparations

Country Status (27)

Country Link
JP (1) JPS52139713A (nl)
AR (1) AR224494A1 (nl)
AT (1) AT351159B (nl)
AU (1) AU508793B2 (nl)
BE (1) BE854640A (nl)
CA (1) CA1085296A (nl)
CS (1) CS208196B2 (nl)
DD (1) DD132232A5 (nl)
DE (1) DE2721785A1 (nl)
DK (1) DK208077A (nl)
ES (1) ES458710A1 (nl)
FI (1) FI771491A (nl)
FR (1) FR2350836A1 (nl)
GB (1) GB1543543A (nl)
GR (1) GR68895B (nl)
HU (1) HU184196B (nl)
IE (1) IE45415B1 (nl)
IL (1) IL52075A (nl)
MX (1) MX5976E (nl)
NL (1) NL7704879A (nl)
NZ (1) NZ183927A (nl)
PL (1) PL111183B1 (nl)
PT (1) PT66514B (nl)
RO (1) RO72935A (nl)
SE (1) SE426780B (nl)
SU (1) SU1218919A3 (nl)
ZA (1) ZA772757B (nl)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5545601A (en) * 1978-09-26 1980-03-31 Toyo Jozo Co Ltd Long-acting cephalexin and its preparation
JPS5659707A (en) * 1979-10-19 1981-05-23 Toyo Jozo Co Ltd Lasting antibiotic pharmaceutical and its preparation
JPS5883613A (ja) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk 硝酸イソソルビト−ル製剤
JPS5883106U (ja) * 1981-11-30 1983-06-06 松下電工株式会社 電磁石装置に於けるオイルダツシユポツト
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
JPS62226926A (ja) * 1986-03-27 1987-10-05 Teisan Seiyaku Kk 持続性複合顆粒剤
JP2008535922A (ja) * 2005-04-12 2008-09-04 エラン・ファルマ・インターナショナル・リミテッド 細菌感染を治療するためのセファロスポリンを含む放出制御組成物

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
JPS5826816A (ja) * 1981-08-11 1983-02-17 Teisan Seiyaku Kk 球形顆粒からなる持続性複合顆粒剤
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
FR2577800B1 (fr) * 1985-02-22 1990-09-07 Grimberg Georges Medicament sous forme galenique gastro-resistante
CN114617855A (zh) * 2020-12-14 2022-06-14 江苏贝佳制药有限公司 头孢氨苄胶囊的制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE JAPANESE JOURNAL OF ANTIBIOTICS=1969 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5545601A (en) * 1978-09-26 1980-03-31 Toyo Jozo Co Ltd Long-acting cephalexin and its preparation
JPS6213324B2 (nl) * 1978-09-26 1987-03-25 Toyo Jozo Kk
JPS5659707A (en) * 1979-10-19 1981-05-23 Toyo Jozo Co Ltd Lasting antibiotic pharmaceutical and its preparation
JPS5883613A (ja) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk 硝酸イソソルビト−ル製剤
JPS6133007B2 (nl) * 1981-11-10 1986-07-31 Tooa Eiyoo Kk
JPS5883106U (ja) * 1981-11-30 1983-06-06 松下電工株式会社 電磁石装置に於けるオイルダツシユポツト
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
JPS6232166B2 (nl) * 1983-06-15 1987-07-13 Shionogi & Co
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
JPH0157090B2 (nl) * 1984-08-10 1989-12-04 Ss Pharmaceutical Co
JPS62226926A (ja) * 1986-03-27 1987-10-05 Teisan Seiyaku Kk 持続性複合顆粒剤
JP2008535922A (ja) * 2005-04-12 2008-09-04 エラン・ファルマ・インターナショナル・リミテッド 細菌感染を治療するためのセファロスポリンを含む放出制御組成物

Also Published As

Publication number Publication date
CS208196B2 (en) 1981-08-31
IL52075A (en) 1980-06-30
AU2507877A (en) 1978-11-16
PT66514B (en) 1978-10-16
FI771491A (nl) 1977-11-14
JPS5547611B2 (nl) 1980-12-01
DE2721785A1 (de) 1977-11-24
AU508793B2 (en) 1980-04-03
GB1543543A (en) 1979-04-04
PL198058A1 (pl) 1979-03-26
BE854640A (fr) 1977-09-01
IL52075A0 (en) 1977-07-31
ES458710A1 (es) 1978-03-01
SE7705502L (sv) 1977-11-14
IE45415L (en) 1977-11-13
MX5976E (es) 1984-09-12
IE45415B1 (en) 1982-08-25
RO72935A (ro) 1982-07-06
PT66514A (en) 1977-06-01
SE426780B (sv) 1983-02-14
AR224494A1 (es) 1981-12-15
DE2721785C2 (nl) 1989-03-16
CA1085296A (en) 1980-09-09
NL7704879A (nl) 1977-11-15
HU184196B (en) 1984-07-30
ATA341877A (de) 1978-12-15
AT351159B (de) 1979-07-10
SU1218919A3 (ru) 1986-03-15
DK208077A (da) 1977-11-14
FR2350836B1 (nl) 1981-02-06
NZ183927A (en) 1980-02-21
GR68895B (nl) 1982-03-15
FR2350836A1 (fr) 1977-12-09
PL111183B1 (en) 1980-08-30
ZA772757B (en) 1978-04-26
DD132232A5 (de) 1978-09-13

Similar Documents

Publication Publication Date Title
JPS53113008A (en) Constant rate releasing preparation
JPS52139713A (en) Sustained release cefalexin preparations
JPS539739A (en) #-trifluoromethyl-##-isoproxybenzoic acid anilide, its preparation and its use
JPS5218811A (en) Preparation of aqueous solution of fat- soluble substances
JPS5340779A (en) Optically active tolpertisone, their preparation and pharmaceuticals containting the same
JPS5318529A (en) Optically active mandelic acid phenylglycinol salt and its preparation
JPS5350150A (en) 1-aminotricyclo(4,3,1,1,2,5)undecane and its preparation
JPS52144656A (en) N-(diphenylphosphonomethyl)-imino-diacetonitrile and its preparation
JPS5346950A (en) (54)1-acetylaminotricyclo(4,3,1,12,5)undecane and its preparation
JPS5430185A (en) Mandelic acid derivative and carcinostatic agnet containing the same
JPS51136886A (en) New biologica lly active substance, ml-236c, and its preparation
JPS537686A (en) 6-oxo-2-piperzinylacetic acid and its preparation
JPS5312878A (en) Preparation of cyanopyrazinecarboxyamide and its preparation
JPS5318551A (en) 4-homoprotoadamantane and its preparation
JPS52133918A (en) Optically active beta-amino acid and its preparation
JPS5223054A (en) Preparation of amino acid derivatives
JPS5231082A (en) Preparation of 2- piperazinophenylpropionic acid
JPS5287140A (en) Preparation of optically active p-hydroxyphenylglycine
JPS5373554A (en) 2, 10-dehydro-4-homobrendane and its preparation
JPS52153906A (en) 1-hexadecyne-6-one and its preparation
JPS52125616A (en) Medical capsules
JPS535136A (en) 2-hydroxy-3-methyl-3-(4-isobutylphenyl)acrylonitrile preparation
JPS52105154A (en) 3##-deoxydihydrostreptomycin and its prepatation
JPS52111562A (en) 2-thienylsulfinylacetic acid and its preparation
JPS5428892A (en) 16m-macrolide-3-hydrolase, its preparation, and its use